Avapritinib has 3 known drug interactions based on U.S. FDA drug labeling data. 2 are classified as major interactions requiring close medical supervision. Notable interactions include combinations with Cyp3a Inducers, Mao Inhibitors, Ethinyl Estradiol. Patients taking Avapritinib should inform their healthcare provider of all current medications — including over-the-counter drugs and supplements — to avoid potentially harmful combinations. Data sourced from OpenFDA and the NIH National Library of Medicine.
- Total
- 3
- Major
- 2
- Moderate
- 1
Major (2)
- Avapritinib + Cyp3a Inducers— Coadministration decreases avapritinib plasma concentrations, which may decrease efficacy of AYVAKIT. Avoid coadministra…
- Avapritinib + Mao Inhibitors— Coadministration increases avapritinib plasma concentrations, which may increase incidence and severity of adverse react…
Moderate (1)
- Avapritinib + Ethinyl Estradiol— Avapritinib may increase ethinyl estradiol exposure, leading to increased risk of ethinyl estradiol-associated adverse r…